BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28286260)

  • 1. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma.
    Singh A; Srivastava N; Yadav A; Ateeq B
    Neoplasia; 2020 Oct; 22(10):497-510. PubMed ID: 32896760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway.
    Lu F; Li C; Sun Y; Jia T; Li N; Li H
    World J Surg Oncol; 2020 Jun; 18(1):147. PubMed ID: 32605563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway.
    Gong M; Wang X; Mu L; Wang Y; Pan J; Yuan X; Zhou H; Xing J; Wang R; Sun J; Liu Q; Zhang X; Wang L; Chen Y; Pei Y; Li S; Liu L; Zhao Y; Yuan Y
    Cancer Sci; 2021 Feb; 112(2):604-618. PubMed ID: 33090636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
    Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
    Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.
    Wang Z; Shi Y; Ying C; Jiang Y; Hu J
    Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
    Hua TNM; Oh J; Kim S; Antonio JM; Vo VTA; Om J; Choi JW; Kim JY; Jung CW; Park MJ; Jeong Y
    Exp Mol Med; 2020 Apr; 52(4):629-642. PubMed ID: 32280134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
    Wang Q; Cai J; Fang C; Yang C; Zhou J; Tan Y; Wang Y; Li Y; Meng X; Zhao K; Yi K; Zhang S; Zhang J; Jiang C; Zhang J; Kang C
    Theranostics; 2018; 8(17):4733-4749. PubMed ID: 30279734
    [No Abstract]   [Full Text] [Related]  

  • 10. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
    Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
    Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP promotes autophagy and progression of gliomas via upregulating HMGB1.
    Zhao M; Zhang Y; Jiang Y; Wang K; Wang X; Zhou D; Wang Y; Yu R; Zhou X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):99. PubMed ID: 33726796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways.
    Mao P; Wang T; Du CW; Yu X; Wang MD
    Mol Biol Rep; 2023 Oct; 50(10):8015-8023. PubMed ID: 37541997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway.
    Li L; Li Z; Meng X; Wang X; Song D; Liu Y; Xu T; Qin J; Sun N; Tian K; Zhong J; Yu D; Song Y; Hou T; Jiang C; Chen Q; Cai J
    Cancer Lett; 2023 Nov; 579():216467. PubMed ID: 38084701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
    Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
    CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex.
    Vadla R; Miki S; Taylor B; Kawauchi D; Jones BM; Nathwani N; Pham P; Tsang J; Nathanson DA; Furnari FB
    bioRxiv; 2023 Jul; ():. PubMed ID: 37461511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma.
    Shi P; Xu J; Cui H
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
    Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
    Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of circulating miRNA as early diagnostic molecular markers in malignant glioblastoma base on decision tree joint scoring algorithm.
    Su F; Liu Y; Zong Y; Gao Z; Zhou G; Deng C; Liu Y; Zeng Y; Ma X; Wang Y; Wu Y; Xu F; Guan L; Liu B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17823-17836. PubMed ID: 37943358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-194-3p represses NF-κB in gliomas to attenuate iPSC genes and proneural to mesenchymal transition.
    Jacob JR; Singh R; Okamoto M; Chakravarti A; Palanichamy K
    iScience; 2024 Jan; 27(1):108650. PubMed ID: 38226170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance.
    Pichol-Thievend C; Anezo O; Pettiwala AM; Bourmeau G; Montagne R; Lyne AM; Guichet PO; Deshors P; Ballestín A; Blanchard B; Reveilles J; Ravi VM; Joseph K; Heiland DH; Julien B; Leboucher S; Besse L; Legoix P; Dingli F; Liva S; Loew D; Giani E; Ribecco V; Furumaya C; Marcos-Kovandzic L; Masliantsev K; Daubon T; Wang L; Diaz AA; Schnell O; Beck J; Servant N; Karayan-Tapon L; Cavalli FMG; Seano G
    Nat Commun; 2024 Apr; 15(1):3602. PubMed ID: 38684700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.